Overview
NVCT market data
Price History
NVCT price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for NVCT. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Nuvectis Pharma's Ciprocopan Receives Marketing Approval From National Medicinal Products Administration Of China To Treat Paroxysmal Nocturnal HemoglobinuriaBenzinga · Jul 23, 2026, 11:31 AM
Ryanair Posts Weak Q1 Results, Joins HDFC Bank And Other Big Stocks Moving Lower In Monday’s Pre-Market SessionBenzinga · Jul 20, 2026, 12:02 PM
IBM To Rally Around 14%? Here Are 10 Top Analyst Forecasts For MondayBenzinga · Jul 6, 2026, 12:25 PM
8-K filing — Nuvectis Pharma, Inc. (NVCT)SEC EDGAR · Jun 30, 2026, 8:43 PM
Concentrix Reports Downbeat Q2 Earnings, Joins Nuvectis Pharma, Vishay Intertechnology And Other Big Stocks Moving Lower In Tuesday’s Pre-Market SessionBenzinga · Jun 30, 2026, 12:05 PM
Nuvectis Pharma Commences Common Stock Offering; Terms UndisclosedBenzinga · Jun 29, 2026, 8:05 PM
HC Wainwright & Co. Maintains Buy on Nuvectis Pharma, Raises Price Target to $39Benzinga · Jun 22, 2026, 3:35 PM
Nuvectis Pharma Strikes License Agreement With Haisco Pharmaceutical Group For Exclusive Ex-China Rights To Two CompoundsBenzinga · Jun 22, 2026, 11:40 AM
HC Wainwright & Co. Maintains Buy on Nuvectis Pharma, Raises Price Target to $13Benzinga · Jun 12, 2026, 6:00 PM